Forms and results of mitolactol therapy

I. Hindy, J. Szanto, I. Bodrogi, E. Farkas, S. Eckhardt

Research output: Contribution to journalArticle

4 Citations (Scopus)


The authors give a summarizing report about mitolactol treatments performed in Hungary. As a single-agent therapy the drug was administered in two forms: (1) every-day therapy, 5 mg/kg/day, (2) push therapy, 10 mg/kg every 5th day or 15 mg/kg every 7th day, in a total dose of 100 mg/kg in both administration forms. Out of the solid tumours the squamous cell cancers proved to be the most responsive to mitolactol therapy: first of all in tumours of the head and neck and of the lung. The study also reports the preliminary results of polychemotherapeutical protocols containing mitolactol now in progress: (1) bleomycin + mitolactol (Bristol protocol), (2) carminomycin + mitolactol and (3) adriamycin + mitolactol.

Original languageEnglish
Pages (from-to)115-117
Number of pages3
JournalUnknown Journal
Issue numberSUPPL.1
Publication statusPublished - Jan 1 1980

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Forms and results of mitolactol therapy'. Together they form a unique fingerprint.

  • Cite this